Underlined by the fact that an certain amount of MM cell lines are more sensitive to MCL1 inhibition and rather less sensitive to BCL2 and BCLXL inhibition, MCL1 might be a superior target than BCL2 [52]. This evidence concerns the gene BCL2 and Miyoshi myopathy.